Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status

34-year-old African American male with a diagnosis of schizophrenia was placed on aripiprazole and risperidone for psychosis and mood stabilization. Two days after medication initiation, the patient's mentation was altered and he appeared confused with an elevated creatine kinase (CK) at 7101....

Full description

Saved in:
Bibliographic Details
Main Authors: Amber N. Edinoff, Hamza Mohammad-Amin, Amira S. Odisho
Format: Article
Language:English
Published: Open Medical Publishing 2022-08-01
Series:Health Psychology Research
Online Access:https://doi.org/10.52965/001c.37530
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823857502538694656
author Amber N. Edinoff
Hamza Mohammad-Amin
Amira S. Odisho
author_facet Amber N. Edinoff
Hamza Mohammad-Amin
Amira S. Odisho
author_sort Amber N. Edinoff
collection DOAJ
description 34-year-old African American male with a diagnosis of schizophrenia was placed on aripiprazole and risperidone for psychosis and mood stabilization. Two days after medication initiation, the patient's mentation was altered and he appeared confused with an elevated creatine kinase (CK) at 7101. Medications were held and CK normalized with IV fluids. Quetiapine was initiated after medical stabilization along with lithium and paliperidone palmitate injections. After the second dose of paliperidone palmitate, the patient's mentation was altered, and repeat CK was 4272. The patient received 4 liters of IV fluid and his mental status returned to baseline. There were two case studies noted that had marked increases in serum CK with risperidone use. The first was in an adolescent who was titrated to a dose of risperidone 3mg/ day but the only abnormality was an increase in his CK levels. The next case report was in a 40-year-old female who was on risperidone 2.5mg /day for one year. She had an intention tremor, minor muscle weakness of the lower extremities with a blood pressure of 140/100 and a pulse of 100. She manifested more clinical signs of possible Neuroleptic Malignant Syndrome (NMS). This case highlights the importance of laboratory investigations when there is a high suspicion of possible NMS. It also highlights that some cases of NMS may only present as altered mental status and increased CK in which quick treatment may lead to the prevention of full-blown clinical manifestations of NMS which could be life-threatening.
format Article
id doaj-art-7c29cea258ae40a48a11e32b62b32065
institution Kabale University
issn 2420-8124
language English
publishDate 2022-08-01
publisher Open Medical Publishing
record_format Article
series Health Psychology Research
spelling doaj-art-7c29cea258ae40a48a11e32b62b320652025-02-11T20:30:33ZengOpen Medical PublishingHealth Psychology Research2420-81242022-08-01103Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental StatusAmber N. EdinoffHamza Mohammad-AminAmira S. Odisho34-year-old African American male with a diagnosis of schizophrenia was placed on aripiprazole and risperidone for psychosis and mood stabilization. Two days after medication initiation, the patient's mentation was altered and he appeared confused with an elevated creatine kinase (CK) at 7101. Medications were held and CK normalized with IV fluids. Quetiapine was initiated after medical stabilization along with lithium and paliperidone palmitate injections. After the second dose of paliperidone palmitate, the patient's mentation was altered, and repeat CK was 4272. The patient received 4 liters of IV fluid and his mental status returned to baseline. There were two case studies noted that had marked increases in serum CK with risperidone use. The first was in an adolescent who was titrated to a dose of risperidone 3mg/ day but the only abnormality was an increase in his CK levels. The next case report was in a 40-year-old female who was on risperidone 2.5mg /day for one year. She had an intention tremor, minor muscle weakness of the lower extremities with a blood pressure of 140/100 and a pulse of 100. She manifested more clinical signs of possible Neuroleptic Malignant Syndrome (NMS). This case highlights the importance of laboratory investigations when there is a high suspicion of possible NMS. It also highlights that some cases of NMS may only present as altered mental status and increased CK in which quick treatment may lead to the prevention of full-blown clinical manifestations of NMS which could be life-threatening.https://doi.org/10.52965/001c.37530
spellingShingle Amber N. Edinoff
Hamza Mohammad-Amin
Amira S. Odisho
Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status
Health Psychology Research
title Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status
title_full Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status
title_fullStr Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status
title_full_unstemmed Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status
title_short Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status
title_sort silent neuroleptic malignant syndrome a case report of atypical antipsychotic induced elevation of creatinine kinase and altered mental status
url https://doi.org/10.52965/001c.37530
work_keys_str_mv AT ambernedinoff silentneurolepticmalignantsyndromeacasereportofatypicalantipsychoticinducedelevationofcreatininekinaseandalteredmentalstatus
AT hamzamohammadamin silentneurolepticmalignantsyndromeacasereportofatypicalantipsychoticinducedelevationofcreatininekinaseandalteredmentalstatus
AT amirasodisho silentneurolepticmalignantsyndromeacasereportofatypicalantipsychoticinducedelevationofcreatininekinaseandalteredmentalstatus